Overview

A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer

Status:
Not yet recruiting

Trial end date:
2025-12-20

Target enrollment:

Participant gender:

Summary

This is a randomized, open-label, parallel, multi-center study, aims to evaluate the efficacy and safety of metronomic chemotherapy with oral Navelbine versus intermittent oral Navelbine in female patients with HER2 negative Metastasis Breast Cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Chinese Academy of Medical Sciences

Treatments:

Vinblastine
Vinorelbine